MARIMED INC. Quarterly Interest Expense in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Marimed Inc. quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q1 2024.
  • Marimed Inc. Interest Expense for the quarter ending March 31, 2024 was $1.63M, a 35% decline year-over-year.
  • Marimed Inc. Interest Expense for the twelve months ending March 31, 2024 was $8.31M, a 114% increase year-over-year.
  • Marimed Inc. annual Interest Expense for 2023 was $9.19M, a 443% increase from 2022.
  • Marimed Inc. annual Interest Expense for 2022 was $1.69M, a 28.1% decline from 2021.
  • Marimed Inc. annual Interest Expense for 2021 was $2.36M, a 76% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $8.31M $1.63M -$876K -35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.19M $1.56M +$1.14M +269% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $8.05M $2.48M +$1.96M +379% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.09M $2.64M +$2.2M +500% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $3.89M $2.51M +$2.19M +700% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $1.69M $422K +$143K +51.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $1.55M $518K +$218K +72.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.33M $440K +$175K +66% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $1.16M $313K -$1.2M -79.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.36M $279K -$1.95M -87.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 $4.31M $300K -$1.62M -84.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $5.93M $265K -$2.7M -91.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $8.63M $1.51M -$1.18M -43.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $9.81M $2.23M -$1.41M -38.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $11.2M $1.92M -$2.6M -57.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $13.8M $2.97M +$350K +13.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $13.5M $2.69M +$751K +38.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $12.7M $3.64M +$357K +10.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $12.4M $4.52M +$4.04M +845% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $8.32M $2.62M +$2.33M +815% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $5.99M $1.94M +$1.62M +514% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $4.37M $3.29M +$2.8M +574% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-01
Q3 2018 $1.57M $478K +$388K +432% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-29
Q2 2018 $1.18M $286K +$190K +197% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $990K $316K +$398K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $592K $488K +$549K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 $43.4K $89.9K +$152K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$108K $96.3K +$171K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$280K -$81.6K +$11.1K +12% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$291K -$61.2K +$14.1K +18.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$305K -$61.8K -$4.5K -7.86% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$300K -$75.1K -$31.5K -72.3% Apr 1, 2016 Jun 30, 2016 10-Q 2016-12-19
Q1 2016 -$269K -$92.7K -$62.4K -206% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$207K -$75.4K -$45.8K -155% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$161K -$57.3K -$33.3K -138% Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-22
Q2 2015 -$128K -$43.6K -$42.3K -3255% Apr 1, 2015 Jun 30, 2015 10-Q 2016-12-19
Q1 2015 -$85.2K -$30.3K -$29K -2235% Jan 1, 2015 Mar 31, 2015 10-Q 2016-11-01
Q4 2014 -$56.2K -$29.6K Oct 1, 2014 Dec 31, 2014 10-K 2016-09-27
Q3 2014 -$24K Jun 30, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 -$1.3K Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 -$1.3K Jan 1, 2014 Mar 31, 2014 10-Q 2015-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.